Table of Contents

Fertility Drug and Surgery Market Research, Insight

The fertility medicine and surgery market is anticipated to reach USD 2.21 billion by 2030, growing at a CAGR of 9.50% from 2022 to 2030.
Fertility Drug and Surgery Market

Market Synopsis

The fertility medicine and surgery market is anticipated to reach USD 2.21 billion by 2030, growing at a CAGR of 9.50% from 2022 to 2030. Some of the major aspects influencing this growth include health factors such as a spike in global infertility rates, increased gamete donations, obesity, and delayed pregnancies. Some economic factors, such as a rise in disposable incomes and healthcare expenditure around the world, are other crucial factors growing the market. Further, a sedentary lifestyle across the globe is the leading cause of rising infertility, which appears to be boosting the demand for treatment and is driving the market growth. In addition to this, a shift from the traditional cultural viewpoint, the rising age of the average pregnant woman, increased health problems such as infertility and obesity, and a rampant surge in sexually transmitted diseases is pushing the boundaries for great expansion in the global market for fertility treatment. Thus, it is seen that increasing awareness about medical procedures is creating plenty of opportunities for the future of family planning. However, negative externalities such as high cost of treatment and medical complications may challenge the market growth during the forecast period.

Regional Analysis

The global fertility drug and surgery market can be segmented on the basis of drug, underlying cause, end-user, procedures, and region.

On the basis of drugs, the global fertility drug and surgery market can be segmented on the basis of clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins.

On the basis of the underlying cause, the global fertility drug and surgery market can be segmented on the basis of male and female

On the basis of end-user, the global fertility drug and surgery market can be segmented on the basis of fertility clinics, hospitals, clinical research institutes, and others.

On the basis of procedures, the global fertility drug and surgery market can be segmented on the basis of hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration)

On the basis of region, the global fertility drug and surgery market research can be segmented on the basis of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Regional Analysis

The global market for fertility drugs and surgery is dominated by the Americas – owing to increasing infertility, obesity, and delayed pregnancies. From an economic perspective, an increase in the disposable income of an average American household adds to the boost in market growth. This trend is closely followed by Europe, who stood second in 2017 in the global fertility drug and surgery market.

On the other hand, Asia Pacific happens to be the fastest-growing region for this market. It is driven by factors such as increasing awareness amongst people and growing healthcare infrastructure in this region.

Lastly, the Middle East and Africa face issues such as abject poverty and failing economics, making the market lag within this region and causing it to have the least share in this market. However, between the Middle East and Africa, the former seems to hold a bigger portion of the market share owing to increased government funding in healthcare programs and the presence of more developed economies including UAE, Kuwait, and Saudi Arabia

Key Players

The established players of the global fertility drug and surgery market are Baxter Healthcare Corporation, Eli Lilly, Ferring Pharmaceuticals, Inc., Noven Pharmaceuticalorganon, Inc., Merck & Co. Pharmaceutical Company, Janssen Pharmaceuticals Inc., Pfizer, Inc., Procter & Gamble Pharmaceuticals, Personal Products Company, Emd Serono, Inc., and others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com

Blog Tags
Blog Category

Leave a Reply